|
Fusion gene ID: 14976 |
FusionGeneSummary for GNL3L_XAGE3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: GNL3L_XAGE3 | Fusion gene ID: 14976 | Hgene | Tgene | Gene symbol | GNL3L | XAGE3 | Gene ID | 54552 | 170626 |
Gene name | G protein nucleolar 3 like | X antigen family member 3 | |
Synonyms | GNL3B | CT12.3a|CT12.3b|GAGED4|PLAC6|XAGE-3|pp9012 | |
Cytomap | Xp11.22 | Xp11.22 | |
Type of gene | protein-coding | protein-coding | |
Description | guanine nucleotide-binding protein-like 3-like proteinG protein nucleolar 3Bguanine nucleotide binding protein-like 3 (nucleolar)-likenovel GTPase | X antigen family member 3CT12.3G antigen, family D, 4cancer/testis antigen 12.3cancer/testis antigen family 12, member 3acancer/testis antigen family 12, member 3bg antigen family D member 4placenta-specific 6placenta-specific gene 6 proteinprote | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | Q9NVN8 | Q8WTP9 | |
Ensembl transtripts involved in fusion gene | ENST00000336470, ENST00000360845, ENST00000489691, | ENST00000375491, ENST00000346279, | |
Fusion gene scores | * DoF score | 4 X 5 X 4=80 | 1 X 1 X 1=1 |
# samples | 6 | 1 | |
** MAII score | log2(6/80*10)=-0.415037499278844 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
Context | PubMed: GNL3L [Title/Abstract] AND XAGE3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | GNL3L | GO:0031647 | regulation of protein stability | 19487455 |
Hgene | GNL3L | GO:0032091 | negative regulation of protein binding | 19487455 |
Hgene | GNL3L | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region | 19487455 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | CESC | TCGA-ZJ-A8QR-01A | GNL3L | chrX | 54556852 | + | XAGE3 | chrX | 52896172 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-5UTR | ENST00000336470 | ENST00000375491 | GNL3L | chrX | 54556852 | + | XAGE3 | chrX | 52896172 | - |
intron-5UTR | ENST00000336470 | ENST00000346279 | GNL3L | chrX | 54556852 | + | XAGE3 | chrX | 52896172 | - |
5UTR-5UTR | ENST00000360845 | ENST00000375491 | GNL3L | chrX | 54556852 | + | XAGE3 | chrX | 52896172 | - |
5UTR-5UTR | ENST00000360845 | ENST00000346279 | GNL3L | chrX | 54556852 | + | XAGE3 | chrX | 52896172 | - |
3UTR-5UTR | ENST00000489691 | ENST00000375491 | GNL3L | chrX | 54556852 | + | XAGE3 | chrX | 52896172 | - |
3UTR-5UTR | ENST00000489691 | ENST00000346279 | GNL3L | chrX | 54556852 | + | XAGE3 | chrX | 52896172 | - |
Top |
FusionProtFeatures for GNL3L_XAGE3 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
GNL3L | XAGE3 |
Stabilizes TERF1 telomeric association by preventingTERF1 recruitment by PML. Stabilizes TERF1 protein by preventingits ubiquitination and hence proteasomal degradation. Does so byinterfering with TERF1-binding to FBXO4 E3 ubiquitin-proteinligase. Required for cell proliferation. By stabilizing TRF1protein during mitosis, promotes metaphase-to-anaphase transition.Stabilizes MDM2 protein by preventing its ubiquitination, andhence proteasomal degradation. By acting on MDM2, may affect TP53activity. Required for normal processing of ribosomal pre-rRNA.Binds GTP. {ECO:0000269|PubMed:16251348,ECO:0000269|PubMed:17034816, ECO:0000269|PubMed:19487455,ECO:0000269|PubMed:21132010}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for GNL3L_XAGE3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for GNL3L_XAGE3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
GNL3L | LDOC1, MDM2, TP53, TERF1, TERT, ELAVL1, SLC2A4, ADRB2, ALAS1, ROPN1, LZTS2, BRCA1, BSG, NT5E, PRSS50, TGOLN2, OLFM4, FTSJ3, GTPBP4, SRP72, NMD3, NOP58, OLA1, PES1, KRAS, HIST1H2BG, HNRNPU, RPL10, SMC3, FTSJ1, EXOSC5, CD70, ERP44, APLNR, LAMP2, PROZ, BBS7, TOR1AIP2, FAM174A, TRIM25 | XAGE3 | HTT, GMCL1, ZNF644, METAP1D, WIZ, EHMT2, EHMT1, GAST, RSPRY1, GTSE1, DEFA5, RNPEPL1, PSMG2, CROCCP2, PSMG1 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for GNL3L_XAGE3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for GNL3L_XAGE3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |